Marios Vetoulas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marios Vetoulas has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Nikos K. Karamanos
Biochemistry, Biochemical Analysis & Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26504 Patras, Greece
2 shared publications - Zoi Piperigkou
Biochemistry, Biochemical Analysis & Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26504 Patras, Greece
2 shared publications - Angeliki Farmaki
Biochemistry, Biochemical Analysis & Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26504 Patras, Greece
1 shared publication - Katerina Mineschou
Biochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26504 Patras, Greece
1 shared publication - Konstantinos Spanopoulos
Biochemistry, Biochemical Analysis & Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, University of Patras, 26504 Patras, Greece
1 shared publication - Maria Dm Vivanco
Cancer Heterogeneity Lab CIC bioGUNE, BRTA Derio Spain
1 shared publication
Latest Publications
- Open Access
Defined Extracellular Matrix Contexts Rewire 3D Breast Cancer Cell Models: Effects of Sulfated Hyaluronan in the Expression of Matrix Effector and Matrix-Based Cell Functional Properties
Background: Breast cancer progression is strongly influenced by tumor cell interactions with the extracellular matrix (ECM). Three-dimensional (3D) cell culture models provide more relevant systems for studying aspects of the tumor microenvironment (TME), including tumor architecture, matrix remodeling and cell-ECM communication. Collagen type I (Col I), fibronectin (FN) and hyaluronan (HA) are key ECM components involved in breast cancer progression. At the same time, integrins act as major matrix-sensing receptors that translate ECM cues into cellular responses. In this study, we investigated how defined ECM contexts regulate functional cell properties in shERβ MDA-MB-231 and Hs578T advanced 3D breast cancer cell models. Methods: Cells were cultured in 2D and 3D systems under matrix-free conditions or in Col I, FN, and mixed Col I/FN environments, in the presence or absence of HA or sulfated HA (sHA). Spheroid growth, matrix-dependent spheroid organization and dissemination were evaluated. In parallel, selected collagen- and fibronectin-associated integrin subunits, together with HA-related molecules including HAS2, CD44, and RHAMM, were analyzed to assess receptor-mediated matrix- and HA-associated responses. Results: Matrix substrates strongly influenced breast cancer spheroid behavior. Col I promoted outward dissemination, whereas FN-containing environments favored compact organization and restricted spreading. HA supported spheroid-like organization in a matrix-dependent manner, whereas sHA disrupted organized spheroid assembly in ECM-rich conditions, resulting in looser structures or smaller cell colonies, depending on the matrix context. Gene expression analysis revealed model-dependent remodeling of matrix- and HA-associated programs, with broader adhesion-related responses in shERβ MDA-MB-231 cells and stronger dimensionality-driven regulation in Hs578T cells. Conclusions: Overall, these findings demonstrate that defined ECM contexts actively regulate breast cancer spheroid behavior and matrix-associated receptor programs. Col I, FN and mixed Col I/FN environments generated distinct 3D phenotypes, affecting spheroid growth, organization and dissemination, while HA/sHA further modified these matrix-dependent responses. This study supports sHA as a functional matrix molecule with anti-cancer relevance and highlights the value of 3D matrix-based models for investigating tumor–matrix communication in breast cancer.
Open AccessDefined Extracellular Matrix Contexts Rewire 3D Breast Cancer Cell Models: Effects of Sulfated Hyaluronan in the Expression of Matrix Effector and Matrix-Based Cell Functional Properties
Background: Breast cancer progression is strongly influenced by tumor cell interactions with the extracellular matrix (ECM). Three-dimensional (3D) cell culture models provide more relevant systems for studying aspects of the tumor microenvironment (TME), including tumor architecture, matrix remodeling and cell-ECM communication. Collagen type I (Col I), fibronectin (FN) and hyaluronan (HA) are key ECM components involved in breast cancer progression. At the same time, integrins act as major matrix-sensing receptors that translate ECM cues into cellular responses. In this study, we investigated how defined ECM contexts regulate functional cell properties in shERβ MDA-MB-231 and Hs578T advanced 3D breast cancer cell models. Methods: Cells were cultured in 2D and 3D systems under matrix-free conditions or in Col I, FN, and mixed Col I/FN environments, in the presence or absence of HA or sulfated HA (sHA). Spheroid growth, matrix-dependent spheroid organization and dissemination were evaluated. In parallel, selected collagen- and fibronectin-associated integrin subunits, together with HA-related molecules including HAS2, CD44, and RHAMM, were analyzed to assess receptor-mediated matrix- and HA-associated responses. Results: Matrix substrates strongly influenced breast cancer spheroid behavior. Col I promoted outward dissemination, whereas FN-containing environments favored compact organization and restricted spreading. HA supported spheroid-like organization in a matrix-dependent manner, whereas sHA disrupted organized spheroid assembly in ECM-rich conditions, resulting in looser structures or smaller cell colonies, depending on the matrix context. Gene expression analysis revealed model-dependent remodeling of matrix- and HA-associated programs, with broader adhesion-related responses in shERβ MDA-MB-231 cells and stronger dimensionality-driven regulation in Hs578T cells. Conclusions: Overall, these findings demonstrate that defined ECM contexts actively regulate breast cancer spheroid behavior and matrix-associated receptor programs. Col I, FN and mixed Col I/FN environments generated distinct 3D phenotypes, affecting spheroid growth, organization and dissemination, while HA/sHA further modified these matrix-dependent responses. This study supports sHA as a functional matrix molecule with anti-cancer relevance and highlights the value of 3D matrix-based models for investigating tumor–matrix communication in breast cancer.
- Top Cited PapersOpen Access
Design and Applications of Extracellular Matrix Scaffolds in Tissue Engineering and Regeneration
Tissue engineering is a growing field with multidisciplinary players in cell biology, engineering, and medicine, aiming to maintain, restore, or enhance functions of tissues and organs. The extracellular matrix (ECM) plays fundamental roles in tissue development, maintenance, and repair, providing not only structural support, but also critical biochemical and biomechanical cues that regulate cell behavior and signaling. Although its specific composition varies across different tissue types and developmental stages, matrix molecules influence various cell functional properties in every tissue. Given the importance of ECM in morphogenesis, tissue homeostasis, and regeneration, ECM-based bioscaffolds, developed through tissue engineering approaches, have emerged as pivotal tools for recreating the native cellular microenvironment. The aim of this study is to present the main categories of these scaffolds (i.e., natural, synthetic, and hybrid), major fabrication techniques (i.e., tissue decellularization and multidimensional bioprinting), while highlighting the advantages and disadvantages of each category, focusing on biological activity and mechanical performance. Scaffold properties, such as mechanical strength, elasticity, biocompatibility, and biodegradability are essential to their function and integration into host tissues. Applications of ECM-based bioscaffolds span a range of engineering and regenerative strategies, including cartilage, bone, cardiac tissue engineering, and skin wound healing. Despite promising advances, challenges remain in standardization, scalability, and immune response modulation, with future directions directed towards improving ECM-mimetic platforms.
Top Cited PapersOpen AccessDesign and Applications of Extracellular Matrix Scaffolds in Tissue Engineering and Regeneration
Tissue engineering is a growing field with multidisciplinary players in cell biology, engineering, and medicine, aiming to maintain, restore, or enhance functions of tissues and organs. The extracellular matrix (ECM) plays fundamental roles in tissue development, maintenance, and repair, providing not only structural support, but also critical biochemical and biomechanical cues that regulate cell behavior and signaling. Although its specific composition varies across different tissue types and developmental stages, matrix molecules influence various cell functional properties in every tissue. Given the importance of ECM in morphogenesis, tissue homeostasis, and regeneration, ECM-based bioscaffolds, developed through tissue engineering approaches, have emerged as pivotal tools for recreating the native cellular microenvironment. The aim of this study is to present the main categories of these scaffolds (i.e., natural, synthetic, and hybrid), major fabrication techniques (i.e., tissue decellularization and multidimensional bioprinting), while highlighting the advantages and disadvantages of each category, focusing on biological activity and mechanical performance. Scaffold properties, such as mechanical strength, elasticity, biocompatibility, and biodegradability are essential to their function and integration into host tissues. Applications of ECM-based bioscaffolds span a range of engineering and regenerative strategies, including cartilage, bone, cardiac tissue engineering, and skin wound healing. Despite promising advances, challenges remain in standardization, scalability, and immune response modulation, with future directions directed towards improving ECM-mimetic platforms.